Cited by 125Virology and Viral DiseasesBacterial Infections and VaccinesVaccine Coverage and Hesitancy

The DOI matches its Crossref record; 20 of the 21 references it cites were found in a registry or an index.

Mumps Vaccine Performance among University Students during a Mumps Outbreak

Cortese, Margaret M., Jordan, Hannah T., Curns, Aaron T., Quinlan, Patricia A., Ens, Kim A., Denning, Patricia M., Dayan, Gustavo H.·2008·Clinical Infectious Diseases

DOI 10.1086/529141

Open this paper in CoChat — free account

Abstract

BACKGROUND: The largest reported mumps outbreak at a US college in 19 years occurred in 2006 at a Kansas university with a 2-dose measles-mumps-rubella (MMR) vaccination policy. We assessed vaccine performance and mumps risk factors, including the possibility of waning vaccine protection. METHODS: Case students were compared with a cohort of the university's approximately 19,000 undergraduates. The secondary attack rate for clinical mumps was determined among roommates exposed to case students. Time from receipt of the second dose of MMR vaccine was compared between case students and roommates without mumps. RESULTS: Coverage with > or =2 dose of MMR vaccine was > or =95% among 140 undergraduate case students and 444 cohort students. The secondary attack rate for clinical mumps among roommates who had received 2 doses of vaccine ranged from 2.2% to 7.7%, depending on the case definition. Compared with roommates without mumps, case students were more likely (odds ratio, 2.46; 95% confidence interval, 1.25-4.82) to have received their second dose of MMR vaccine > or =10 years earlier. The odds of being a case student increased with each 1-year increase in time from receipt of the second dose of MMR vaccine (odds ratio, 1.36; 95% confidence interval, 1.10-1.68) among case students and roommates aged 18-19 years but not among those aged > or =20 years. Students aged 18-19 years had a higher risk of mumps (risk ratio, 3.14; 95% confidence interval, 1.60-6.16), compared with students aged > or =22 years; women living in dormitories had increased risk of mumps (risk ratio, 1.95; 95% confidence interval, 1.01-3.76), compared with men not living in dormitories. CONCLUSION: High 2-dose MMR coverage protected many students from developing mumps but was not sufficient to prevent the mumps outbreak. Vaccine-induced protection may wane. Similar US settings where large numbers of young adults from wild-type naive cohorts live closely together may be at particular risk for mumps outbreaks.

Integrity signals

Registry

Crossref · 10.1086/529141

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Report of the Committee on Infectious Diseases
Nider, H. (1989) · Archives of Dermatology · doi:10.1001/archderm.1989.01670190156031 · Cited by 1,911
Summary of notifiable diseases--United States, 2002.
Groseclose, S. L., Brathwaite, W. S., Hall, P. A., Connor, F. J., Sharp, P., Anderson, W. J., Fagan, R. F., Javier, A. J., Jones, G. F., Nitschke, D. A., et al. (2004) · PubMed · Cited by 1,338
Measles, Mumps, and Rubella--Vaccine Use and Strategies for Elimination of Measles, Rubella, and Congenital Rubella Syndrome and Control of Mumps: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Watson, J., Hadler, S. C., Dykewicz, C. A., Reef, S. E., & Phillips, L. (1998) · PsycEXTRA Dataset · doi:10.1037/e547712006-001 · Cited by 584
Immunisation and herd immunity
Anderson, R. M., & May, R. M. (1990) · The Lancet · doi:10.1016/0140-6736(90)90420-a · Cited by 328
INFECTIOUSNESS OF COMMUNICABLE DISEASES IN THE HOUSEHOLD
Simpson, R. E. H. (1952) · The Lancet · doi:10.1016/s0140-6736(52)91357-3 · Cited by 302
Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England
Cohen, C., White, J. M., Savage, E. J., Glynn, J. R., Choi, Y., Andrews, N., Brown, D., & Ramsay, M. E. (2007) · Emerging infectious diseases · doi:10.3201/eid1301.060649 · Cited by 241
Sustained Transmission of Mumps in a Highly Vaccinated Population: Assessment of Primary Vaccine Failure and Waning Vaccine-Induced Immunity
Briss, P. A., Fehrs, L. J., Parker, R. A., Wright, P. F., Sannella, E. C., Hutcheson, R. H., & Schaffner, W. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.1.77 · Cited by 163
Mumps outbreak in a highly vaccinated population
Hersh, B. S., Fine, P., Kent, W. K., Cochi, S. L., Kahn, L. H., Zell, E. R., Hays, P. L., & Wood, C. L. (1991) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)80726-7 · Cited by 159
Summary of notifiable diseases --- United States, 2005.
McNabb, S. J. N., Jajosky, R. A., Hall-Baker, P. A., Adams, D. A., Sharp, P., Anderson, W. J., Javier, A. J., Jones, G. J., Nitschke, D. A., Worshams, C. A., et al. (2007) · PubMed · Cited by 147
The effectiveness of the mumps component of the MMR vaccine: a case control study
Harling, R., White, J. M., Ramsay, M. E., Macsween, K. F., & Bosch, C. V. D. (2005) · Vaccine · doi:10.1016/j.vaccine.2004.10.020 · Cited by 132

Show all 21 references

Research works printed but not linked: 12

McNabb SJ, 2007, MMWR Morb Mortal Wkly Rep, 54, 1
Centers, 1982, MMWR Morb Mortal Wkly Rep, 31, 617
Watson JC, 1998, MMWR Recomm Rep, 47, 1
Centers, 1989, MMWR Morb Mortal Wkly Rep, 38, 388
Centers, 2006, MMWR Morb Mortal Wkly Rep, 55, 1152
Centers, 2006, MMWR Morb Mortal Wkly Rep, 55, 559
Centers for Disease Control and Prevention. Mumps epidemic-Iowa, 2006. MMWR Morb Mortal Wkly Rep 2006; 55:366-8.
Centers, 1997, MMWR Recomm Rep, 46, 1
Mumps, 2006, IL: American Academy of Pediatrics, 464
Cochi SL, 1988, Am J Dis Child, 142, 499
Cohen C, 2007, England. Emerg Infect Dis, 13, 12
Meyer MB, 1962, Am J Hyg, 75, 259

Sorted by citations

IMMUNIZATION OF HEALTH-CARE PERSONNEL: RECOMMENDATIONS OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP)
Shefer, A. M., & Atkinson, W. W. (2011) · Cited by 647
Recent Resurgence of Mumps in the United States
Dayan, G. H., Quinlisk, M. P., Parker, A. A., Barskey, A. E., Harris, M. L., Schwartz, J. M. H., Hunt, K., Finley, C., Leschinsky, D. P., O’Keefe, A. L., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706589 · Cited by 400
Self-citation
Vaccines for measles, mumps and rubella in children
Demicheli, V., Rivetti, A., Debalini, M. G., & Di Pietrantonj, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004407.pub3 · Cited by 372
Molecular biology, pathogenesis and pathology of mumps virus
Rubin, S. A., Eckhaus, M., Rennick, L. J., Bamford, C., & Duprex, W. P. (2014) · The Journal of Pathology · doi:10.1002/path.4445 · Cited by 254
Vaccines for measles, mumps, rubella, and varicella in children
Pietrantonj, C. D., Rivetti, A., Marchione, P., Debalini, M. G., & Demicheli, V. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004407.pub4 · Cited by 202
Effectiveness of a Third Dose of MMR Vaccine for Mumps Outbreak Control
Cardemil, C. V., Dahl, R. M., James, L., Wannemuehler, K. A., Gary, H. E., Shah, M. P., Marin, M., Riley, J., Feikin, D. R., Patel, M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1703309 · Cited by 177
Recommendation of the Advisory Committee on Immunization Practices for Use of a Third Dose of Mumps Virus–Containing Vaccine in Persons at Increased Risk for Mumps During an Outbreak
Marin, M., Marlow, M. A., Moore, K. L., & Patel, M. (2018) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6701a7 · Cited by 175
Mumps Outbreak in Orthodox Jewish Communities in the United States
Barskey, A. E., Schulte, C., Rosen, J. B., Handschur, E. F., Rausch-Phung, E., Doll, M. K., Cummings, K. P., Alleyne, E. O., High, P., Lawler, J., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202865 · Cited by 169
Mumps Outbreaks in Vaccinated Populations: Are Available Mumps Vaccines Effective Enough to Prevent Outbreaks?
Dayan, G. H., & Rubin, S. A. (2008) · Clinical Infectious Diseases · doi:10.1086/591196 · Cited by 167
Self-citation
Mumps resurgences in the United States: A historical perspective on unexpected elements
Barskey, A. E., Glasser, J. W., & LeBaron, C. W. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.06.109 · Cited by 151
Vaccine waning and mumps re-emergence in the United States
Lewnard, J. A., & Grad, Y. H. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aao5945 · Cited by 150
Current Status of Mumps Virus Infection: Epidemiology, Pathogenesis, and Vaccine
Su, S., Chang, H.-L., & Chen, K. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17051686 · Cited by 120
The increasing incidence of mumps orchitis: a comprehensive review
Davis, N. F., McGuire, B. B., Mahon, J. A., Smyth, A. E., O’Malley, K., & Fitzpatrick, J. M. (2010) · British Journal of Urology · doi:10.1111/j.1464-410x.2009.09148.x · Cited by 115
Recent Mumps Outbreaks in Vaccinated Populations: No Evidence of Immune Escape
Rubin, S. A., Link, M. A., Sauder, C. J., Zhang, C., Ngo, L., RIMA, B. K., & Duprex, W. P. (2011) · Journal of Virology · doi:10.1128/jvi.06125-11 · Cited by 109
Waning immunity against mumps in vaccinated young adults, France 2013
Vygen, S., Fischer, A., Meurice, L., Njoya, I. M., Gregoris, M., Ndiaye, B., Ghenassia, A., Poujol, I., Stahl, J. ‐., Antona, D., et al. (2016) · Eurosurveillance · doi:10.2807/1560-7917.es.2016.21.10.30156 · Cited by 101
Vaccines for measles, mumps, rubella, and varicella in children
Pietrantonj, C. D., Rivetti, A., Marchione, P., Debalini, M. G., & Demicheli, V. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004407.pub5 · Cited by 114
Epidemic of Mumps among Vaccinated Persons, the Netherlands, 2009–2012
Sane, J., Gouma, S., Koopmans, M., de Melker, H. E., Swaan, C. M., van Binnendijk, R. S., & Hahné, S. J. M. (2014) · Emerging infectious diseases · doi:10.3201/eid2004.131681 · Cited by 96
Persistence of Mumps Antibodies after 2 Doses of Measles‐Mumps‐Rubella Vaccine
LeBaron, C. W., Forghani, B., Beck, C., Brown, C., Bi, D., Cossen, C. K., & Sullivan, B. J. (2008) · The Journal of Infectious Diseases · doi:10.1086/596207 · Cited by 93
Mumps Orchitis: Clinical Aspects and Mechanisms
Wu, H. J., Wang, F., Tang, D., & Han, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.582946 · Cited by 89
Mumps Complications and Effects of Mumps Vaccination, England and Wales, 2002–2006
Yung, C.-F., Andrews, N. J., Bukasa, A., Brown, K. E., & Ramsay, M. E. (2011) · Emerging infectious diseases · doi:10.3201/eid1704.101461 · Cited by 87
Mumps Antibody Levels Among Students Before a Mumps Outbreak: In Search of a Correlate of Immunity
Cortese, M. M., Barskey, A. E., Tegtmeier, G. E., Zhang, C., Ngo, L., Kyaw, M. H., Baughman, A. L., Menitove, J. E., Hickman, C. J., Bellini, W. J., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir526 · Cited by 86
Self-citation
Mumps: an Update on Outbreaks, Vaccine Efficacy, and Genomic Diversity
Lam, E., Rosen, J. B., & Zucker, J. R. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00151-19 · Cited by 84
Measles, mumps, and rubella in Finland: 25 years of a nationwide elimination programme
Peltola, H., Jokinen, S., Paunio, M., Hovi, T., & Davidkin, I. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70282-2 · Cited by 82
Ongoing mumps outbreak in a student population with high vaccination coverage, Netherlands, 2010
Whelan, J., van Binnendijk, R. S., Greenland, K., Fanoy, E. B., Khargi, M., Yap, K.-B., Boot, H. J., Veltman, N., Swaan, C. M., van der Bij, A., et al. (2010) · Eurosurveillance · doi:10.2807/ese.15.17.19554-en · Cited by 80
Mumps Outbreak at a University and Recommendation for a Third Dose of Measles-Mumps-Rubella Vaccine — Illinois, 2015–2016
Albertson, J., Clegg, W. J., Reid, H. D., Arbise, B. S., Pryde, J. A., Vaid, A., Thompson-Brown, R., & Echols, F. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6529a2 · Cited by 76
Mumps Outbreaks in Vaccinated Populations—Is It Time to Re-assess the Clinical Efficacy of Vaccines?
Connell, A. R., Connell, J., Leahy, T. R., & Hassan, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02089 · Cited by 73
Mumps outbreak among vaccinated university students associated with a large party, the Netherlands, 2010
Greenland, K., Whelan, J., Fanoy, E. B., Borgert, M. J., Hulshof, K., Yap, K.-B., Swaan, C. M., Donker, T., van Binnendijk, R. S., de Melker, H. E., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.083 · Cited by 72
Mumps outbreak in a highly vaccinated student population, The Netherlands, 2004
Brockhoff, H., Mollema, L., Sonder, G. J. B., Postema, C. A., van Binnendijk, R. S., Kohl, R., de Melker, H. E., & Hahné, S. J. M. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.02.020 · Cited by 67
Seroepidemiology of mumps in Europe (1996–2008): why do outbreaks occur in highly vaccinated populations?
Eriksen, J., Davidkin, I., Kafatos, G., Andrews, N. J., Bárbara, C., Cohen, D., Duks, A., Griškevičius, A., Johansen, K., Bartha, K., et al. (2012) · Epidemiology and Infection · doi:10.1017/s0950268812001136 · Cited by 65
Decreased humoral immunity to mumps in young adults immunized with MMR vaccine in childhood
Rasheed, M. A. U., Hickman, C. J., McGrew, M., Sowers, S. B., Mercader, S., Hopkins, A., Grimes, V., Yu, T., Wrammert, J., Mulligan, M. J., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1905570116 · Cited by 62
Resurgence of Mumps in Korea
Park, S. H. (2015) · Infection and Chemotherapy · doi:10.3947/ic.2015.47.1.1 · Cited by 61
Investigation of a mumps outbreak among university students with two measles–mumps–rubella (MMR) vaccinations, Virginia, September–December 2006
Rota, J. S., Turner, J. C., Yost-Daljev, M. K., Freeman, M., TONEY, D. M., Meisel, E., Williams, N. J., Sowers, S. B., Lowe, L., Rota, P. A., et al. (2009) · Journal of Medical Virology · doi:10.1002/jmv.21557 · Cited by 52
Mumps outbreak in Israel's highly vaccinated society: are two doses enough?
Anis, E., Grotto, I., Moerman, L., Warshavsky, B., Slater, P. E., & LEV, B. (2011) · Epidemiology and Infection · doi:10.1017/s095026881100063x · Cited by 51
Vaccines for measles, mumps and rubella in children
Demicheli, V., Rivetti, A., Debalini, M. G., & Pietrantonj, C. D. (2013) · Evidence-Based Child Health A Cochrane Review Journal · doi:10.1002/ebch.1948 · Cited by 52
Guidance for Isolation Precautions for Mumps in the United States: A Review of the Scientific Basis for Policy Change
Kutty, P. K., Kyaw, M. H., Dayan, G. H., Brady, M. T., Bocchini, J. A., Reef, S. E., Bellini, W. J., & Seward, J. F. (2010) · Clinical Infectious Diseases · doi:10.1086/652770 · Cited by 51
Self-citation
Mumps Outbreak in a Highly Vaccinated University-Affiliated Setting Before and After a Measles-Mumps-Rubella Vaccination Campaign—Iowa, July 2015–May 2016
Shah, M. P., Quinlisk, P., Weigel, A., Riley, J., James, L., Patterson, J., Hickman, C. J., Rota, P. A., Stewart, R. J., Clemmons, N. S., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix718 · Cited by 49
Emergent lineages of mumps virus suggest the need for a polyvalent vaccine
May, M. A., Rieder, C. A., & Rowe, R. J. (2017) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2017.09.024 · Cited by 47
MMR vaccination and disease elimination: the Finnish experience
Davidkin, I., Kontio, M., Paunio, M., & Peltola, H. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.99 · Cited by 46
Mumps Outbreak Among a Highly Vaccinated University Community—New York City, January–April 2014
Patel, L. N., Arciuolo, R. J., Fu, J., Giancotti, F. R., Zucker, J. R., Rakeman, J. L., & Rosen, J. B. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw762 · Cited by 45
Waning Immunity and Microbial Vaccines—Workshop of the National Institute of Allergy and Infectious Diseases
Gu, X., Plotkin, S. A., Edwards, K. M., Sette, A., Mills, K. H. G., Levy, O., Sant, A. J., Mo, A. X. Y., Alexander, W., Lu, K. T., et al. (2017) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00034-17 · Cited by 45
Knowledge gaps persist and hinder progress in eliminating mumps
Ramanathan, R., Voigt, E. A., Kennedy, R. B., & Poland, G. A. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.05.067 · Cited by 44
Emerging Mumps Infection
Rubin, S. A., Kennedy, R. B., & Poland, G. A. (2016) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001182 · Cited by 42
Mumps epidemiology in the Mid-West of Ireland 2004-2008: increasing disease burden in the university/college setting
Whyte, D., O'Dea, F., McDonnell, C., O’Connell, N. H., Callinan, S., Brosnan, E., Powell, J., Monahan, R., FitzGerald, R., Mannix, M., et al. (2009) · Eurosurveillance · doi:10.2807/ese.14.16.19182-en · Cited by 42
Mumps outbreak and laboratory diagnosis
Maillet, M., Bouvat, E., Robert, N., Baccard-Longère, M., Morel-Baccard, C., Morand, P., Vabret, A., & Stahl, J. ‐. (2014) · Journal of Clinical Virology · doi:10.1016/j.jcv.2014.11.004 · Cited by 38
Characteristics of Large Mumps Outbreaks in the United States, July 2010–December 2015
Clemmons, N. S., Redd, S. B., Gastañaduy, P. A., Marin, M., Patel, M., & Fiebelkorn, A. P. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy779 · Cited by 38
Mumps vaccine effectiveness and risk factors for disease in households during an outbreak in New York City
Livingston, K. A., Rosen, J. B., Zucker, J. R., & Zimmerman, C. M. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.11.021 · Cited by 35
Mumps Outbreak in the Republic of Moldova, 2007–2008
Schwarz, N. G., Bernard, H., Melnic, A., Bucov, V., Caterinciuc, N., der Heiden, M. A., Andrews, N. J., Pebody, R. G., Aidyralieva, C., & Hahné, S. J. M. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181d743df · Cited by 33
Mumps outbreaks: A problem in need of solutions
Principi, N., & Esposito, S. (2018) · Journal of Infection · doi:10.1016/j.jinf.2018.03.002 · Cited by 33
Risk Factors for Mumps at a University with a Large Mumps Outbreak
Huang, A. S.-E., Cortese, M. M., Curns, A. T., Bitsko, R. H., Jordan, H. T., Soud, F., Villalon-Gomez, J. M., Denning, P. M., Ens, K. A., Hanson, G. R., et al. (2009) · Public Health Reports · doi:10.1177/003335490912400311 · Cited by 33
Self-citation
Protective effect of vaccination against mumps complications, Czech Republic, 2007–2012
Orlíková, H., Malý, M., Lexová, P., Šebestová, H., Limberková, R., Jurzykowská, L., & Kynčl, J. (2016) · BMC Public Health · doi:10.1186/s12889-016-2958-4 · Cited by 30
Risk Factors for Transmission of Mumps in a Highly Vaccinated Population in Orange County, NY, 2009–2010
Kutty, P. K., McLean, H. Q., Lawler, J., Schulte, C., Hudson, J. M., Blog, D. S., & Wallace, G. S. (2013) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000020 · Cited by 30
Large outbreak of mumps virus genotype G among vaccinated students in Norway, 2015 to 2016
Veneti, L., Borgen, K., Borge, K. S., Danis, K., Greve‐Isdahl, M., Konsmo, K., Njølstad, G., Nordbø, S. A., Øystese, K. S., Rykkvin, R., et al. (2018) · Eurosurveillance · doi:10.2807/1560-7917.es.2018.23.38.1700642 · Cited by 29
Modelling and analysis of global resurgence of mumps: A multi-group epidemic model with asymptomatic infection, general vaccinated and exposed distributions
Liu, Z., Hu, J., & Wang, L. (2017) · Nonlinear Analysis Real World Applications · doi:10.1016/j.nonrwa.2017.02.009 · Cited by 27
Assessing Mumps Outbreak Risk in Highly Vaccinated Populations Using Spatial Seroprevalence Data
Abrams, S., Beutels, P., & Hens, N. (2014) · American Journal of Epidemiology · doi:10.1093/aje/kwu014 · Cited by 25
Mumps outbreaks in four universities in the North West of England: Prevention, detection and response
Kay, D., Roche, M., Atkinson, J., Lamden, K., & Vivancos, R. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.03.037 · Cited by 25
Isolation compliance among university students during a mumps outbreak, Kansas 2006
Soud, F., Cortese, M. M., Curns, A. T., Edelson, P. J., Bitsko, R. H., Jordan, H. T., HUANG, A. S., Villalon-Gomez, J. M., & Dayan, G. H. (2008) · Epidemiology and Infection · doi:10.1017/s0950268808000629 · Cited by 25
Self-citation
Mumps Virus Nucleoprotein and Hemagglutinin-Specific Antibody Response Following a Third Dose of Measles Mumps Rubella Vaccine
Latner, D. R., Fiebelkorn, A. P., McGrew, M., Williams, N. J., Coleman, L. A., McLean, H. Q., Rubin, S. A., & Hickman, C. J. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx263 · Cited by 25
Modelling the Transmission Dynamics and Control of Mumps in Mainland China
Li, Y., Liu, X., & Wang, L. (2017) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15010033 · Cited by 25
Roles of Sialic Acid, AXL, and MER Receptor Tyrosine Kinases in Mumps Virus Infection of Mouse Sertoli and Leydig Cells
Wang, F., Chen, R., Jiang, Q., Wu, H. J., Gong, M., Liu, W., Yu, X., Zhang, W., Han, R., Liu, A., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01292 · Cited by 25
Safety and Immunogenicity of M-M-RII (Combination Measles–Mumps–Rubella Vaccine) in Clinical Trials of Healthy Children Conducted Between 1988 and 2009
Kuter, B. J., Brown, M. L. H., Wiedmann, R. T., Hartzel, J. S., & Musey, L. K. (2016) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001241 · Cited by 24
Commentary
Plotkin, S. A. (2013) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3182809dda · Cited by 22
Epidemiology and the economic assessment of a mumps outbreak in a highly vaccinated population, Orange County, New York, 2009–2010
Kutty, P. K., Lawler, J., Rausch-Phung, E., Ortega‐Sanchez, I. R., Goodell, S., Schulte, C., Pollock, L., Valure, B., Hudson, J., Gallagher, K., et al. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.28389 · Cited by 22
Mumps vaccine
Rubin, S. A., & Plotkin, S. A. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00007-0 · Cited by 23
Challenges in Interpretation of Diagnostic Test Results in a Mumps Outbreak in a Highly Vaccinated Population
Trotz‐Williams, L. A., Mercer, N. J., Paphitis, K., Walters, J. M., Wallace, D., Kristjanson, E., Gubbay, J. B., & Mazzulli, T. (2016) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00542-16 · Cited by 20
Viral mumps: Increasing occurrences in the vaccinated population
Lau, R. K., & Turner, M. D. (2019) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2019.06.012 · Cited by 20
Assessment of mumps virus-specific antibodies by different serological assays: which test correlates best with mumps immunity?
Allwinn, R., Zeidler, B., Steinhagen, K., Rohwäder, E., Wicker, S., Rabenau, H. F., & Doerr, H. W. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1216-z · Cited by 20
Mumps Vaccines
Rubin, S. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00039-0 · Cited by 20
High risk of mumps infection in children who received one dose of mumps-containing vaccine: waning immunity to mumps in children aged 2-5 years from kindergartens in Jiangsu Province, China
Sun, X. Y., Tang, F., Hu, Y., Deng, X., Wang, Z., Zhou, M., & Liu, Y. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1708162 · Cited by 19
Resurgence of Vaccine-Preventable Diseases in the United States: Anesthetic and Critical Care Implications
Porteous, G. H., Hanson, N. A., Sueda, L. A., Hoaglan, C. D., Dahl, A. B., Ohlson, B. B., Schmidt, B. E., Wang, C. C., & Fagley, R. E. (2016) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000001196 · Cited by 18
Mumps is Back: Why is Mumps Eradication Not Working?
MacDonald, N. E., Hatchette, T. F., Elkout, L., & Sarwal, S. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-7185-2_14 · Cited by 17
Sero-prevalence of mumps antibodies in subpopulations subsequently affected by a large scale mumps epidemic in Israel
Muhsen, K., Shohat, T., Aboudy, Y., Mendelson, E., Algor, N., Anis, E., & Cohen, D. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.03.047 · Cited by 17
Mumps virus pathogenesis: Insights and knowledge gaps
Gouma, S., Koopmans, M., & van Binnendijk, R. S. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1210745 · Cited by 17
Prevention of measles, mumps and rubella: 40 years of global experience with M-M-R II
Kuter, B. J., Marshall, G. S., FERGIE, J. E., Schmidt, E., & Pawaskar, M. D. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.2007710 · Cited by 18
Long time persistence of antibodies against Mumps in fully MMR immunized young adults: an Italian retrospective cohort study
Bianchi, F. P., Nitto, S. D., Stefanizzi, P., Larocca, A. M. V., Germinario, C. A., & Tafuri, S. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1735861 · Cited by 15
Loss of protective immunity of two-dose mumps-containing vaccine over time: concerns with the new strategy of the mumps immunization program in China
Wang, D., Nie, T., Pan, F., Wang, Y., Wang, J., & Qin, W. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1861877 · Cited by 15
Perceptions of mumps and MMR vaccination among university students in England: An online survey
Bolton-Maggs, D., Conrad, D. C., Keenan, A., Lamden, K., Ghebrehewet, S., & Vivancos, R. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.05.078 · Cited by 15
Mumps epidemic dynamics in the United States before vaccination (1923–1932)
Pomeroy, L. W., Magsi, S., McGill, S., & Wheeler, C. E. (2023) · Epidemics · doi:10.1016/j.epidem.2023.100700 · Cited by 12
Mumps-containing vaccine effectiveness during outbreaks in two schools in Guangdong, China, 2012
Wang, M., Zhao, J., Wang, T., Hao, L., Ma, C., Su, Q., & Luo, H. (2012) · Western Pacific surveillance response journal · doi:10.5365/wpsar.2012.3.4.012 · Cited by 11
Identifying a Level of Neutralizing Antibody That Correlates With Protection From Clinical Mumps Disease During a 2017 Mumps Outbreak Among Military Service Members
Sowers, S. B., Clemmons, N. S., Mercader, S., Nielsen, L. E., Colley, H., Jordan, N. N., Bettger, C., Masters, N. B., Markelz, A. E., & Hickman, C. J. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae329 · Cited by 10
Mumps: A year of enhanced surveillance in Catalonia, Spain
Domı́nguez, Á., de la Fuente, M. O., Torner, N., Carmona, G., Costa, J. M., Caylà, J. A., Sala, M. R., Barrabeig, I., Camps, N., & Minguell, S. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.03.022 · Cited by 10
Epidemiologic features of mumps in Taiwan from 2006 to 2011: a new challenge for public health policy
Chen, C.-C., Lu, C.-C., Su, B.-H., & Chen, K. (2014) · World Journal of Pediatrics · doi:10.1007/s12519-014-0525-6 · Cited by 10
Effectiveness of one dose of mumps vaccine against clinically diagnosed mumps in Guangzhou, China, 2006–2012
Fu, C., Xu, J., Cai, Y., He, Q., Zhang, C., Chen, J., Dong, Z., Hu, W., Wang, H., Zhu, W. J., et al. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.26113 · Cited by 10
Australian vaccine preventable disease epidemiological review series: mumps 2008-2012
Bag, S. K., Dey, A., Wang, H., & Beard, F. (2015) · Communicable Diseases Intelligence · doi:10.33321/cdi.2015.39.2 · Cited by 10
Lower Long-term Immunogenicity of Mumps Component After MMR Vaccine
de Laval, F., Haus, R., Spiegel, A., & Simon, F. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181f2d864 · Cited by 10
Impact of vaccine effectiveness and coverage on preventing large mumps outbreaks on college campuses: Implications for vaccination strategy
Melgar, M., Yockey, B., & Marlow, M. A. (2022) · Epidemics · doi:10.1016/j.epidem.2022.100594 · Cited by 9
Genetic characteristics of mumps viruses isolated in Korea from 2007 to 2012
Kim, S. T., Kim, Y., Yang, J., Nam, J., Kim, K., Kim, S. S., & Kang, H. J. (2016) · Journal of Medical Virology · doi:10.1002/jmv.24515 · Cited by 8
Assessing the Changes of Mumps Characteristics with Different Vaccination Strategies Using Surveillance Data: Importance to Introduce the 2‐Dose Schedule in Quzhou of China
Zhou, C., Song, W., Yin, Z., Li, S., Gong, X., Fang, Q., & Wang, S. (2020) · Journal of Immunology Research · doi:10.1155/2020/8130760 · Cited by 8
Assessing seropositivity of MMR antibodies in individuals aged 2–22: evaluating routine vaccination effectiveness after the 2003 mass campaign-a study from Iran’s National Measles Laboratory
Ghafoori, F., Mokhtari‐Azad, T., Foroushani, A. R., Farahmand, M., Shadab, A., & Salimi, V. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09593-6 · Cited by 7
Epidemiological characteristics and serological survey of mumps 15 years after MMR vaccine was included in the immunization program
Gong, X., Fang, Q., Zheng, W., Lai, S., Xu, W., & Yin, Z. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29856 · Cited by 7
Public health advice based on routine mumps surveillance in England and Wales
Yung, C. F., Bukasa, A., Brown, K. E., & Pebody, R. G. (2010) · Eurosurveillance · doi:10.2807/ese.15.38.19669-en · Cited by 7
Epidemic of complicated mumps in previously vaccinated young adults in the South-West of France
Vareil, M.-O., Rouibi, G., Kassab, S., Soula, V., Duffau, P., Lafon, M., Neau, D., & Cazanave, C. (2014) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2014.09.006 · Cited by 6
Mumps Transmission Control Status and Inapparent Infection Rate among Middle and High School Students during the 2007-2008 Mumps Outbreak in Daegu
Kim, K. H., Kim, C. H., Choi, B. Y., Go, U. Y., Lee, D. H., & Ki, M. (2009) · Journal of Preventive Medicine and Public Health · doi:10.3961/jpmph.2009.42.6.408 · Cited by 5
Measles, mumps, rubella and varicella antibodies among international and domestic university students
Dyda, A., Broome, A., Rawlinson, W. D., Mahimbo, A., Saha, A., Kefalas, B., Seale, H., MacIntyre, C. R., Zwar, N. A., Gidding, H. F., et al. (2024) · Journal of Travel Medicine · doi:10.1093/jtm/taae004 · Cited by 5
Evaluation and optimization of mumps-containing vaccination strategies: a study based on an individual-based stochastic model
Wang, Y., Yang, T., Guo, X., Wu, Y., He, Y., Wang, L., Zhao, Z., & Chen, T. (2025) · EClinicalMedicine · doi:10.1016/j.eclinm.2025.103620 · Cited by 4
Detection of mumps virus genotype H in two previously vaccinated patients from Mexico City
del Valle, A., García, A. A., & Barrón, B. L. (2016) · Archives of Virology · doi:10.1007/s00705-016-2770-6 · Cited by 4
Mumps outbreaks in ethnic subpopulations: what can we learn?
Westphal, D. W., & Bowen, A. C. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30652-2 · Cited by 4
Identification and description of mumps cases in a non-outbreak setting and evaluation of the effectiveness of mumps-containing vaccines over time
Zerbo, O., Modaressi, S., Glanternik, J. R., Goddard, K., Ross, P., Lewis, N., & Klein, N. P. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1756153 · Cited by 3
No evidence of mumps transmission during air travel, United States, November 1, 2006–October 31, 2010
Nelson, K. R., Marienau, K. J., Barskey, A. E., & Schembri, C. (2012) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2012.06.003 · Cited by 3
Mumps outbreak in Copperbelt province, Zambia: Epidemiological characteristics
Chirambo, R. M., Songolo, P., Masaninga, F., & Kazembe, L. N. (2018) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2018.09.005 · Cited by 2
Why Do Vaccine-Preventable Disease Outbreaks Occur in the United States?
Cherry, J. D., & Harriman, K. H. (2012) · Cited by 2

Authors: Cortese, M. M., Jordan, H. T., Curns, A. T., Quinlan, P. A., Ens, K. A., Denning, P. M., & Dayan, G. H.
Affiliations: Centers for Disease Control and Prevention (US)
University of Kansas (US)
ORCID: Cortese, Margaret M.
Jordan, Hannah T.
Curns, Aaron T.
Venue: Clinical Infectious Diseases
Publisher: Oxford University Press (OUP)
Published: 2008-04-15
Volume: 46
Issue: 8
Pages: 1172-1180
ISSN: 1058-4838 (ISSN-L)
1537-6591
DOI: 10.1086/529141
OpenAlex: W2148035675
Cited by: 125
References: 21
Citations by year: 2025: 6 · 2024: 5 · 2023: 4 · 2022: 4 · 2021: 4 · 2020: 9 · 2019: 4 · 2018: 8 · 2017: 11 · 2016: 13 · 2015: 3 · 2014: 8 · 2013: 7 · 2012: 8
FWCI: 7.60
Type: journal article
Language: en
Open access: closed
Locations: Clinical Infectious Diseases (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
Social Sciences › Health › Vaccine Coverage and Hesitancy
Keywords: mumps, mumps vaccine, MMR vaccine, vaccine waning, vaccination coverage, mumps outbreak, university students, secondary attack rate, dormitory life, young adults, risk factors
MeSH terms: Disease Outbreaks, Female, Humans, Kansas, Male, Mumps, Mumps Vaccine, Students, Universities, Cohort Studies, Measles-Mumps-Rubella Vaccine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mumps Vaccine Performance among University Students during a Mumps Outbreak

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks